Form 4: Rallybio Corp Director Paula Soteropoulos Acquires Options

Director Paula Soteropoulos acquired options to purchase 16,500 shares of Rallybio Corp common stock on May 15, 2024.

Summary

• Paula Soteropoulos, a director of Rallybio Corp, filed a Form 4 on May 17, 2024, reporting a transaction.
• On May 15, 2024, Soteropoulos acquired options to purchase 16,500 shares of Rallybio Corp common stock at an exercise price of $1.91.
• The options were granted under the company's 2021 Equity Incentive Plan and vest on the earlier of May 15, 2025, or the date of the company's 2025 Annual Meeting of Stockholders.
• Following the transaction, Soteropoulos directly owns options for 16,500 shares.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing and does not inherently convey positive or negative sentiment. It simply reports a transaction.

Positives

• The acquisition of options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This is a standard SEC filing related to insider transactions. It is common for directors and officers of publicly traded companies to receive stock options as part of their compensation packages.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment if viewed as a sign of confidence by a company director.

Key Dates